Evidence map›Paper›PMID 42471611›Full record

ArticleBMC psychiatry2026

Borderline personality disorder and substance use disorder: a clinical and psychopathological investigation.

Paola Bozzatello, Claudio Brasso, Giacomo Marin, Gabriele Lerda, Paola Rocca, Silvio Bellino

Abstract read
In one paragraph

Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Paola Bozzatello *Center for Personality Disorders, Psychiatric Clinic, Department of Neurosciences "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy. paola.bozzatello@unito.it.
Claudio Brasso *Center for Personality Disorders, Psychiatric Clinic, Department of Neurosciences "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.
Giacomo MarinCenter for Personality Disorders, Psychiatric Clinic, Department of Neurosciences "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.
Gabriele LerdaCenter for Personality Disorders, Psychiatric Clinic, Department of Neurosciences "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.
Paola RoccaCenter for Personality Disorders, Psychiatric Clinic, Department of Neurosciences "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.
Silvio BellinoCenter for Personality Disorders, Psychiatric Clinic, Department of Neurosciences "Rita Levi Montalcini", University of Turin, Via Cherasco 15, 10126, Turin, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBorderline Personality Disorder (BPD) is a severe psychiatric condition frequently associated with Substance Use Disorder (SUD), with high rates of comorbidity and poor clinical outcomes. Impulsivity and emotional dysregulation are core features shared by both disorders, suggesting common underlying mechanisms. However, less is known about the role of additional factors-such as alexithymia, coping strategies, and quality of life in contributing to dual diagnosis and SUD severity in individuals with BPD. This study aims to: (1) examine the clinical and demographic variables in a sample of patients with BPD comorbid with SUD, in comparison with a group of patients with BPD alone, and (2) identify clinical and psychopathological factors related to the presence of SUD and severity of SUD symptoms in the whole sample (BPD with and without SUD).

methodsSeventy-five outpatients diagnosed with BPD were recruited and divided into two groups: BPD with comorbid SUD (n = 43) and BPD without SUD (n = 32). Diagnoses were established using SCID-5-CV and SCID-5-PD. Participants were assessed using validated instruments measuring BPD severity (BPDSI-IV), impulsivity (BIS-11), alexithymia (TAS-20), coping strategies (CISS), addiction vulnerability and severity (ABQ), quality of life (SAT-P), and functioning (SOFAS). Group differences were analyzed using chi-square and ANCOVA. Hierarchical logistic and linear regressions were conducted to identify factors associated with the SUD presence and severity.

resultsPatients with BPD and SUD were more frequently male and showed earlier BPD onset, greater symptom severity, higher impulsivity, higher vulnerability to addiction, greater alexithymia, and more use of task-oriented coping strategies. Logistic regression showed that impulsivity and vulnerability to SUD were significantly associated with comorbid SUD, while alexithymia reduced the effect of gender. Motor impulsiveness independently contributed to the presence of dual diagnosis. Linear regression analyses indicated that alexithymia and impulsivity were variables most strictly associated with SUD severity, jointly explaining approximately 60% of the variance. Specifically, difficulty describing feelings and externally oriented thinking contributed to a greater SUD severity.

conclusionsImpulsivity and alexithymia appear to be key transdiagnostic factors underlying both the presence and severity of SUD in individuals with BPD. These findings highlight the importance of targeting deficits in emotional processing and impulse control in clinical interventions to improve outcomes in this clinical population.

Indexed as

Affective SymptomsBorderline Personality DisorderSubstance-Related DisordersAdaptation, PsychologicalAdultComorbidityCoping SkillsDiagnosis, Dual (Psychiatry)FemaleHumansImpulsive BehaviorMaleMiddle AgedPsychiatric Status Rating ScalesQuality of LifeSeverity of Illness IndexAddictive behaviorAlexithymiaBorderline personality disorderCoping strategiesImpulsivitySubstance use disordersVulnerability

Identifiers

PMID42471611
PMCPMC13670779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.